Related Experiment Videos
Pharmacodynamics of fluoroquinolones
1Department of Chest and Infectious Diseases, City Hospital Zehlendorf/Heckeshorn, Berlin, Germany.
Summary
Fluoroquinolone antibiotics kill bacteria based on concentration, similar to aminoglycosides. Optimizing fluoroquinolone dosage by considering patient pharmacokinetics and bacterial susceptibility enhances treatment outcomes.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Fluoroquinolones are potent antimicrobials against aerobic gram-negative bacilli.
- Their efficacy is concentration-dependent, with a postantibiotic effect, similar to aminoglycosides.
Purpose of the Study:
- To investigate the pharmacokinetic/pharmacodynamic (PK/PD) drivers for optimizing fluoroquinolone dosing.
- To establish the relationship between drug exposure and treatment outcomes in gram-negative infections.
Main Methods:
- Review of animal studies and clinical trials, primarily using ciprofloxacin.
- Analysis of concentration-dependent killing, postantibiotic effect, peak concentration/MIC ratio, and AUC/MIC ratio (AUIC).
Main Results:
- High peak concentration/MIC ratios (>10-20:1) in animal models correlated with improved survival.
- In patient studies, the AUC/MIC ratio (AUIC) emerged as the key predictor of clinical and microbiological cure.
Conclusions:
- Fluoroquinolone dosing should be individualized based on patient PK and pathogen susceptibility.
- PK/PD principles, particularly AUIC, guide optimal fluoroquinolone therapy for gram-negative infections.